Malabre Richard C

SVP, Chief Accounting Officer at AKBA

Sold, on record
$239k
Dollars the filings state
Form 4 sales
4
Latest Feb 2, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • AKBAAkebia Therapeutics, Inc.SVP, Chief Accounting Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale AKBARoutine
    Feb 3, 2025 2025

    Sold 30,202 shares at $2.10 ($63k)

    Malabre Richard C, SVP, Chief Accounting Officer

    10b5-1 planSold 9.7% of holdings ($652k position)280,248 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AKBARoutine
    Jun 4, 2025 +121 days

    Sold 13,334 shares at $3.53 ($47k)

    Malabre Richard C, SVP, Chief Accounting Officer

    10b5-1 planSold 4.8% of holdings ($989k position)266,914 shares leftFiling

  3. 3 Form 4 sale AKBARoutine
    Jun 9, 2025 +5 days

    Sold 15,000 shares at $4.01 ($60k)

    Malabre Richard C, SVP, Chief Accounting Officer

    10b5-1 planSold 5.3% of holdings ($1.1M position)266,914 shares leftFiling

  4. 4 Form 4 sale AKBAUnusual
    Feb 2, 2026 +238 days

    Sold 49,524 shares at $1.39 ($69k)

    Malabre Richard C, SVP, Chief Accounting Officer

    10b5-1 planSold 14.2% of holdings ($485k position)299,390 shares left3.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Malabre Richard C
Source
Feb 2, 2026Feb 4, 2026AKBASVP, Chief Accounting OfficerForm 4 sale49,524$69k14.2%UnusualSEC
Jun 9, 2025Jun 11, 2025AKBASVP, Chief Accounting OfficerForm 4 sale15,000$60k5.3%RoutineSEC
Jun 4, 2025Jun 5, 2025AKBASVP, Chief Accounting OfficerForm 4 sale13,334$47k4.8%RoutineSEC
Feb 3, 2025Feb 4, 2025AKBASVP, Chief Accounting OfficerForm 4 sale30,202$63k9.7%RoutineSEC